At YoungerMeMD , we see the end of peptide therapy not as an ending, but as a beginning
Any future prescribing decisions should involve a thorough individual riskbenefit assessment, ideally conducted by a clinician with expertise in obesity medicine or endocrinology
If you have concerns about heart rate changes or any other symptoms while taking a GLP-1 receptor agonist, do not discontinue the medication without consulting your prescriber
Special Considerations for Patients With a History of Gallstones If you have a history of gallbladder disease, you should be especially cautious when considering or using GLP-1 medications
If you have concerns, you can ask the pharmacy about their compounding process, the purity of their ingredients, and if they do any batch testing
As a matter of fact, the MDA levels monitored in retinas treated with this compound in the presence of methylcellulose are only mildly reduced (Figure 4a, central bar), and therefore the apoptotic cell death monitored in our model system is not only due to an oxidative stress